In one paragraphArticle in JCO precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Shogen BokuDepartment of Clinical Oncology, Kansai Medical University Hospital, Hirakata City, Osaka, Japan.ORCID 0000-0002-5015-0379 Takao FujisawaDepartment of the Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East, Kashiwa City, Chiba, Japan.ORCID 0009-0002-3438-5757 Shigenori KadowakiDepartment of Clinical Oncology, Aichi Cancer Center Hospital, Chikusa-ku, Nagoya City, Aichi, Japan.ORCID 0000-0001-9923-5309 Hironaga SatakeDepartment of Medical Oncology, Kochi Medical School, Kohasu, Oko-cho, Nankoku City, Kochi, Japan.ORCID 0000-0001-7629-6803 Hisateru YasuiDepartment of Medical Oncology, Kobe City Medical Center General Hospital, Chuo-ku, Kobe City, Hyogo, Japan.ORCID 0000-0001-5563-5802 Koushiro OhtsuboDepartment of Medical Oncology, Kanazawa University Hospital, Kanazawa City, Ishikawa, Japan.
Yasushi ShimizuDepartment of Medical Oncology, Hokkaido University Hospital, Kita-ku, Sapporo, Hokkaido, Japan.
Tomoyuki OtsukaDepartment of Medical Oncology, Osaka International Cancer Institute, Chuo-ku, Osaka City, Osaka, Japan.ORCID 0000-0003-3394-0720 Bunya KuzeDepartment of Head and Neck Surgery, Central Japan International Medical Center, Minokamo, Gifu, Japan.
Riu YamashitaDepartment of the Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East, Kashiwa City, Chiba, Japan.ORCID 0000-0003-0068-6949 Taro ShibukiDepartment of the Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East, Kashiwa City, Chiba, Japan.ORCID 0000-0001-7302-7691 Yoshiaki NakamuraDepartment of the Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East, Kashiwa City, Chiba, Japan.ORCID 0000-0002-5241-6855 Hideaki BandoDepartment of the Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East, Kashiwa City, Chiba, Japan.ORCID 0000-0001-5041-2765 Takayuki YoshinoDepartment of the Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East, Kashiwa City, Chiba, Japan.ORCID 0000-0002-0489-4756 Susumu OkanoDepartment of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa City, Chiba, Japan.ORCID 0000-0001-6639-9753 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42385108
PMCPMC13336687
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390